Oct. 6, 2009 (PR Newswire) --

TARRYTOWN, N.Y., Oct. 6 /PRNewswire-FirstCall/ -- State, county and local government leaders today joined senior management from Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) and BioMed Realty Trust, Inc. (NYSE: BMR) to celebrate the completion of Regeneron's new 229,000 square foot corporate headquarters and research facility at BioMed's The Landmark at Eastview campus in Tarrytown, New York. Featured speakers at the ceremony were Leonard S. Schleifer, M.D., Ph.D., Founder, President and Chief Executive Officer of Regeneron; Kent Griffin, President and Chief Financial Officer of BioMed; Susan Tolchin, Deputy Westchester County Executive; New York State Senator Suzi Oppenheimer; Paul Feiner, Greenburgh Town Supervisor; and Dennis Mullen, Chairman and Chief Executive Officer Designate of the Empire State Development Corporation.

(Logo: http://www.newscom.com/cgi-bin/prnh/20091005/BIOMEDLOGO)

(Logo: http://www.newscom.com/cgi-bin/prnh/20091005/REGENERONLOGO)

The $115 million investment in this state-of-the-art complex, one of the largest corporate facilities to be built in Westchester County in recent years, represents a major commitment to the county and state by Regeneron and BioMed and solidifies The Landmark at Eastview as the region's premier life science campus.

"Our new headquarters and research facility at Landmark provide the efficient and modern facilities we need for our operations," said Dr. Schleifer. "BioMed has provided the critical facilities and expertise that have effectively supported our expansion in Westchester County. We are also pleased to share this celebration with our neighbors and civic leaders in the county, our corporate home since 1989 and an area that cultivates important scientific development."

Regeneron, a fully integrated biopharmaceutical company that discovers, develops and commercializes medicines for the treatment of serious medical conditions including cancer, gout, and retinal and other diseases, will use the new facilities for its research and development laboratories, clinical development staff, corporate headquarters and administrative offices. With the two new buildings, Regeneron now occupies approximately 390,000 square feet in four buildings on the 116 acre Landmark campus. Regeneron, which had just four employees when it opened its research laboratories at The Landmark at Eastview in 1989, now has over 1,000 employees. Regeneron's full-scale manufacturing facility is in Rensselaer, New York.

In his comments at the ribbon cutting, Mr. Griffin said, "Regeneron has been a model partner for BioMed throughout our association.